PROFUSA PE Ratio 2022-2021 | PFSA

Current and historical p/e ratio for PROFUSA (PFSA) from 2022 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. PROFUSA PE ratio as of July 29, 2025 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

PROFUSA PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2025-07-29 0.88 0.00
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.010B $0.000B
Profusa Inc. is a commercial stage digital health company pioneering the next generation of technology platform enabling the continuous monitoring of an individual's biochemistry. Profusa Inc., formerly known as NorthView Acquisition Corp., is based in BERKELEY, Calif.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $47.813B 60.83
Hims & Hers Health (HIMS) United States $13.134B 136.46
Doximity (DOCS) United States $11.457B 53.04
Tempus AI (TEM) United States $10.733B 0.00
IRhythm Technologies (IRTC) United States $4.377B 0.00
Inspire Medical Systems (INSP) United States $3.856B 60.24
Hinge Health (HNGE) United States $3.535B 0.00
Privia Health (PRVA) United States $2.402B 164.17
10x Genomics (TXG) United States $1.803B 0.00
Schrodinger (SDGR) United States $1.643B 0.00
Phreesia (PHR) United States $1.614B 0.00
Azenta (AZTA) United States $1.562B 72.62
Enovis (ENOV) United States $1.561B 8.70
Clover Health Investments (CLOV) United States $1.527B 0.00
Omnicell (OMCL) United States $1.358B 23.97
Evolent Health (EVH) United States $1.133B 96.50
Claritev (CTEV) United States $0.664B 0.00
Fulgent Genetics (FLGT) United States $0.549B 0.00
Standard BioTools (LAB) United States $0.539B 0.00
Veradigm (MDRX) United States $0.507B 0.00
Butterfly Network (BFLY) United States $0.480B 0.00
Talkspace (TALK) United States $0.428B 128.00
TruBridge (TBRG) United States $0.347B 771.00
Outset Medical (OM) United States $0.320B 0.00
Health Catalyst (HCAT) United States $0.285B 0.00
Nyxoah SA (NYXH) Belgium $0.244B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.224B 0.00
CapsoVision (CV) United States $0.202B 0.00
Zepp Health (ZEPP) Netherlands $0.199B 0.00
KORU Medical Systems (KRMD) United States $0.157B 0.00
American Well (AMWL) United States $0.136B 0.00
Pulmonx (LUNG) United States $0.124B 0.00
EUDA Health Holdings (EUDA) Singapore $0.123B 0.00
MDxHealth SA (MDXH) Belgium $0.120B 0.00
CareCloud (CCLD) United States $0.104B 3.95
ImmunoPrecise Antibodies (IPA) Canada $0.092B 0.00
Insight Molecular Diagnostics (IMDX) United States $0.080B 0.00
111 (YI) China $0.061B 0.00
P3 Health Partners (PIII) United States $0.050B 0.00
HeartBeam (BEAT) United States $0.043B 0.00
Zhongchao (ZCMD) China $0.026B 0.00
Streamline Health Solutions (STRM) United States $0.023B 0.00
Precipio (PRPO) United States $0.022B 0.00
Bullfrog AI Holdings (BFRG) United States $0.014B 0.00
Predictive Oncology (POAI) United States $0.008B 0.00
MSP Recovery (MSPR) United States $0.008B 0.00
Strata Skin Sciences (SSKN) United States $0.008B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Movano (MOVE) United States $0.005B 0.00
Tivic Health Systems (TIVC) United States $0.004B 0.00
Evaxion - (EVAX) Denmark $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00
Healthcare Triangle (HCTI) United States $0.000B 0.00